LONDON (Dow Jones)--Proteome Sciences PLC (PRM.LN), a life sciences company delivering content for personalised medicine, said Friday it has received notification from the Civil Division of the Higher Regional Court in Frankfurt that the Court now intends to take witness evidence at the end of July in connection with the company's warranty claim against Sanofi-Avantis Deutschland GmbH. MAIN FACTS: -It isn't anticipated that a decision will be immediately forthcoming from that hearing. -Company continues to believe that it has a strong claim against Sanofi. -Proteome shares closed Thursday at 21.75 pence valuing the company at GBP31.13 million. -By Ian Walker, Dow Jones Newswires; 44-20-7842-9296; [email protected] (END) Dow Jones Newswires June 18, 2010 02:25 ET (06:25 GMT)